Elevated Urinary Oxalate Levels clinical trials at UCSF
1 research study open to eligible people
A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels
open to eligible people ages 18 years and up
The primary purpose of this study is to evaluate the effect of lumasiran on the percent change in urinary oxalate excretion in patients with recurrent calcium oxalate kidney stone disease.
San Francisco, California and other locations